Approval · Notice of Compliance 17457 · 2015
3TC: Notice of Compliance 17457
Issued November 9, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17457
- Date
- November 9, 2015
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of once daily dosing regimen for pediatric patients 3 monts and older
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| 3TC | Not yet assigned | — |
Medicinal ingredients
- LAMIVUDINE 150 MG per TAB
- LAMIVUDINE 300 MG per TAB
- LAMIVUDINE 10 MG per ML